Skip to content

Clinical trials

Observational Venous Thromboembolism trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Venous Thromboembolism Phase: Observational Clear all

290 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20014
20023
20031
20041
20054
20068
20073
20086
20098
201011
201115
20127
201313
201410
201514
201614
201717
201820
201911
202020
202117
202215
202316
202415
202511
202614

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed172
Unknown status48
Recruiting32
Terminated13
Active, not recruiting9
Not yet recruiting8
Withdrawn7
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer19
University Hospital, Brest8
Brigham and Women's Hospital7
Bristol-Myers Squibb7
Ottawa Hospital Research Institute6
Boehringer Ingelheim5
Fondazione Policlinico Universitario Agostino Gemelli IRCCS5
Beijing Tsinghua Chang Gung Hospital4
Center for Epidemiology and Health Research, Germany4
National Heart, Lung, and Blood Institute (NHLBI)4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Venous Thromboembolism290
Pulmonary Embolism76
Venous Thrombosis73
Neoplasms27
Thrombosis23
Thromboembolism21
Atrial Fibrillation19
Cardiovascular Diseases15
Hemorrhage10
COVID-197

Trials

Showing 76 to 100 of 290. Each trial links to its page on Pharma Observatory.

190 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.